Signify Bio is a biotechnology company that develops platforms for targeted delivery of therapeutic proteins using the body's natural protein production capabilities.

Persist AI develops an AI-driven robotics Cloud Lab platform to accelerate pharmaceutical formulation development.

Therini Bio, Inc. develops fibrin-targeting immunotherapies to treat neurodegenerative diseases such as Alzheimer's Disease and Diabetic Macular Edema.

Stylus Medicine develops precision genetic medicines using therapeutic-grade recombinases and lipid nanoparticle delivery to enhance and simplify CAR-T therapies.

HAYA Therapeutics develops precision RNA-guided therapeutics targeting long non-coding RNA for treating aggressive solid tumors and other diseases.

Grove Biopharma is a biotechnology company developing a platform for creating novel therapies targeting intracellular protein-protein interactions, particularly for oncology applications.

Solu Therapeutics develops therapies to selectively eliminate disease-driving cells in cancer and immunology, focusing on conditions like chronic myelomonocytic leukemia.

Augustine Therapeutics is a biotechnology company developing therapies for neuromuscular, neurodegenerative, and cardio-metabolic diseases through selective inhibition of the HDAC6 enzyme.

Ampersand Biomedicines develops smart medicines using their AND™ platform to precisely target specific areas in the body for improved therapeutic effects in immuno-inflammation and immuno-oncology.

TRIMTECH Therapeutics is a biotech company developing targeted protein degradation therapeutics for neurodegenerative diseases using TRIMTAC degrader molecules.

Orbis Medicines develops oral macrocycle drugs as alternatives to biologic drugs using their nGen platform, which combines automated chemistry and machine learning.

Revisto uses AI-driven automation to streamline and enhance pharmaceutical marketing compliance by optimizing the medical, legal, and regulatory review process.

TRexBio is a biotechnology company developing novel therapies for inflammatory diseases using their Deep Biology platform to focus on immune homeostasis.

Sunbird Bio develops a blood-based diagnostic platform for early and accurate detection of neurological disorders like Alzheimer’s and Parkinson’s disease.

Arda Therapeutics develops targeted cell depletion therapies for chronic diseases.

Aktis Oncology is a clinical-stage biotechnology company developing a proprietary radiopharmaceutical pipeline, including Nectin-4-targeted miniprotein radioconjugates, for cancer treatment.

NanoSyrinx is a synthetic biotech company developing a nano syringe delivery platform for intracellular delivery of biologic therapeutics.

OrsoBio, Inc. is a clinical-stage biopharmaceutical company developing novel mitochondrial protonophore therapies targeting obesity and associated metabolic disorders.

Alto Neuroscience specializes in precision psychiatry, developing targeted medicines based on its Precision Psychiatry Platform™, which utilizes brain biomarkers to match patients with appropriate treatments.

ViaNautis Bio specializes in nano-engineered polymer technology, PolyNaut®, which enables targeted intracellular delivery of therapeutic payloads.

OrsoBio, Inc. is a clinical-stage biopharmaceutical company developing novel mitochondrial protonophore therapies targeting obesity and associated metabolic disorders.

Laverock Therapeutics is a UK-based biotech company that develops a gene silencing platform for advanced human therapeutic applications, with a focus on regenerative medicine and immuno-oncology.

Sitryx Therapeutics is a biopharmaceutical company that develops disease-modifying therapeutics for chronic autoimmune and inflammatory diseases by targeting and regulating cell metabolism.

Mariana Oncology is a biotechnology company that develops targeted peptide-based radiopharmaceuticals for the treatment of cancer, with a focus on delivering optimized radiation doses to solid tumors.